Start your visit

Home / Oxytocin Library / Research Tracker

The Oxytocin Research Tracker

The research on intranasal oxytocin is genuinely mixed. Small lab studies found effects on trust, couples’ communication and fear responses, but the largest clinical trial found no benefit, several famous findings didn’t replicate reliably, and many studies were too small. This tracker summarizes 15 key studies so you can judge for yourself.

Key takeaways

  • Promising findings are mostly from small, single-dose lab studies.
  • The largest trial (290 children with autism, 24 weeks) found no benefit over placebo.
  • Short-term research doses have been generally well tolerated.
  • Oxytocin heightens social cues; it isn’t uniformly “pro-social.”

Verdict key: Promising, early Mixed or small Not supported Critique / methods

Not supported Autism · 2021

Daily oxytocin for 24 weeks in children with autism

Sikich et al., New England Journal of Medicine (2021) · Randomized, placebo-controlled trial, 24 weeks · 290 children and adolescents (ages 3–17)

Daily intranasal oxytocin did not significantly improve social or cognitive functioning compared with placebo. The largest trial of its kind, and a key reason to be skeptical of early small studies.

Find this study on PubMed

Critique / methods Methods · 2016

Are intranasal oxytocin studies big enough?

Walum, Waldman & Young, Biological Psychiatry (2016) · Statistical review · Published intranasal oxytocin studies

Found that many intranasal oxytocin studies were too small to reliably detect real effects, meaning published positive results are likely to overstate the true effect.

Find this study on PubMed

Critique / methods Methods · 2016

How much intranasal oxytocin reaches the brain?

Leng & Ludwig, Biological Psychiatry (2016) · Critical review · Review of pharmacology evidence

Argued that only a tiny fraction of a nasal dose is likely to reach the brain, and that some behavioral effects may come from oxytocin acting elsewhere in the body.

Find this study on PubMed

Promising, early Appetite · 2015

Single dose and calorie intake in men

Lawson et al., Obesity (2015) · Randomized, placebo-controlled crossover · 25 men

A single dose modestly reduced how many calories men ate at a later meal, especially from fat. Small, short-term, and not a weight-loss treatment.

Find this study on PubMed

Mixed or small Relationships · 2014

Oxytocin and couples' sexual experience

Behnia et al., Hormones and Behavior (2014) · Placebo-controlled, within-couple · 29 heterosexual couples

Effects were small: some participants reported modest changes in how intense or content they felt after intimacy, while most measures did not change.

Find this study on PubMed

Promising, early Relationships · 2012

Partnered men and social distance

Scheele et al., Journal of Neuroscience (2012) · Placebo-controlled · Healthy men

Men in monogamous relationships who received oxytocin kept a greater distance from an attractive woman they had just met; single men did not. An interesting lab finding, not a clinical outcome.

Find this study on PubMed

Promising, early Safety · 2011

Safety and side effects of intranasal oxytocin in research

MacDonald et al., Psychoneuroendocrinology (2011) · Systematic review of randomized trials · Dozens of randomized trials

Short-term doses used in research (roughly 18–40 IU) produced no reliable side effects or noticeable subjective changes in controlled settings. Long-term safety is much less studied.

Find this study on PubMed

Mixed or small Autism · 2010

Emotion recognition in youth with autism

Guastella et al., Biological Psychiatry (2010) · Randomized, placebo-controlled crossover · Small sample of adolescent males

A single dose improved performance on a test of reading emotions from the eyes. Later, larger trials of repeated dosing were less encouraging.

Find this study on PubMed

Promising, early Anxiety · 2010

Amygdala response in social anxiety disorder

Labuschagne et al., Neuropsychopharmacology (2010) · Placebo-controlled brain imaging · Adults with generalized social anxiety disorder and controls

Oxytocin dampened the heightened amygdala response to fearful faces seen in social anxiety. A brain-activity finding, not proof of symptom relief.

Find this study on PubMed

Mixed or small Trust · 2010

Oxytocin and in-group versus out-group behavior

De Dreu et al., Science (2010) · Placebo-controlled experiments · Healthy men

Oxytocin increased trust and cooperation toward one's own group, and defensiveness toward competing groups. Evidence that oxytocin is not simply a 'be nice to everyone' hormone.

Find this study on PubMed

Promising, early Relationships · 2009

Oxytocin during couple conflict

Ditzen et al., Biological Psychiatry (2009) · Double-blind, placebo-controlled · 47 heterosexual couples

Couples given oxytocin before a conflict discussion showed more positive relative to negative communication and lower cortisol (a stress hormone). Encouraging, but a single lab study.

Find this study on PubMed

Mixed or small Anxiety · 2009

Oxytocin with exposure therapy for social anxiety

Guastella et al., Biological Psychiatry (2009) · Randomized, placebo-controlled trial · Men with social anxiety disorder

Oxytocin improved how participants rated their own speech performance, but did not improve overall therapy outcomes compared with placebo.

Find this study on PubMed

Mixed or small Trust · 2009

Oxytocin, envy and gloating

Shamay-Tsoory et al., Biological Psychiatry (2009) · Placebo-controlled · Healthy adults

In a game of chance, oxytocin increased feelings of envy and gloating. Oxytocin seems to make social cues feel more important, in both directions.

Find this study on PubMed

Mixed or small Trust · 2005

Oxytocin and trust in an investment game

Kosfeld et al., Nature (2005) · Double-blind, placebo-controlled · Healthy men

Investors given oxytocin entrusted more money to a stranger; the effect did not appear when they played against a computer. Hugely influential, but later replication attempts were mixed.

Find this study on PubMed

Summaries are written by the Bondwell Editorial Team from the published research for general education. They are not medical advice, and a single study rarely settles a question. Spot an error or a study we should add? Tell us; corrections are logged per our corrections policy. You may cite or reuse this tracker with attribution under CC BY 4.0.